HCG - NEWER TREATMENT MODALITY FOR TYPE 2 DIABETES MELLITUS (T2DM)

摘要

The present invention discloses a method of treating Type 2 Diabetes(T2DM) and associated co-morbid conditions of Metabolic syndrome (Met S), Insulin sensitivity and physiological testosterone deficient related complications using hCG which could either be used singly or in combination with anti -diabetic agent(s). The present invention further disclose a pharmaceutical combination of hCG with one or more anti diabetic agents thereof for treating Type 2 Diabetes(T2DM) and associated co-morbid conditions of Metabolic syndrome (Met S), Insulin sensitivity and physiological testosterone deficient related complications.